Somanetics Corporation (NASDAQ: SMTS) focuses on developing, manufacturing and marketing the INVOS® Cerebral/Somatic Oximeter. This non-invasive patient monitoring system constantly measures changes in the blood oxygen levels in patients with or at risk for restricted blood flow. The INVOS System also provides the information necessary to identify oxygen imbalances in tissues beneath the sensor, allowing medical professionals to take corrective action. For further information, visit the Company’s web site at www.somanetics.com.
- 18 years ago
QualityStocks
Somanetics Corporation (NASDAQ: SMTS)
Tags Rodman & Renshaw
Related Post
-
Wild Gold Discovery Drill Holes with Gold Over 200 Meters Intercepts at Lafleur Minerals (CSE: LFLR) (OTCQB: LFLRF) Swanson Gold Deposit Point Towards a District-Scale Gold Discovery
Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF)and may include paid advertising.…
-
HeartBeam Inc. (NASDAQ: BEAT) Tackles Heart Disease with Next-Generation ECG Solutions
Cardiovascular disease remains the leading cause of death in the United States. One of the…
-
Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) Positions for Next Phase of Commercial Space Infrastructure Expansion
Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.…